Loading clinical trials...
Loading clinical trials...
Prospective, unmasked, randomized evaluation of the iStent in patients with primary open-angle glaucoma. Patients will be randomized to one of two groups: 1) iStent, or 2) medication.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Glaukos Corporation
NCT00655096 · Eye Diseases
NCT06943599 · Age Related Macular Degeneration, Diabetic Retinopathy, and more
NCT07539675 · Primary Angle-Closure Glaucoma
NCT07322302 · Trachoma, Eye Diseases, and more
NCT06289491 · Glaucoma, Glaucoma, Open-Angle
SV Malayan Ophthalmological Center
Yerevan
Allgemeines Krankenhaus Wien
Vienna
CHU de Lyon Hopital Edouard Herriot
Lyon
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions